Mitsuyoshi Uzawa
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Retraction notice to "Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes" [Diabetes Res. Clin. Pr. 93 (2011) 166-173].
Journal: Diabetes research and clinical practice
Published: April 24, 2025
Retraction Note: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.
Journal: Clinical rheumatology
Published: June 18, 2021
Retraction Note: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.
Journal: Clinical rheumatology
Published: June 18, 2021
Editorial Expression of Concern: Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.
Journal: Clinical rheumatology
Published: June 18, 2021
Retraction Note to: Effect of alendronate on bone mineral density and bone turnovermarkers in post-gastrectomy osteoporotic patients.
Journal: Journal of bone and mineral metabolism
Published: February 06, 2021
Retraction Note to: Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
Journal: Aging clinical and experimental research
Published: November 16, 2019
Retraction Note: Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction: A Retrospective Study.
Journal: Drugs & aging
Published: August 17, 2019
Establishment of an appropriate fall prevention program: A community-based study.
Journal: Geriatrics & gerontology international
Published: November 25, 2015
Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.
Journal: Clinical rheumatology
Published: August 17, 2014
Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I.
Journal: Therapeutics and clinical risk management
Published: January 08, 2013
Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures.
Journal: Therapeutics and clinical risk management
Published: May 02, 2012
Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without renal dysfunction: a retrospective study.
Journal: Drugs & aging
Published: January 12, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026